Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors.
Vincenzo VeneritoPasquale StefanizziMarco FornaroFabio CacciapagliaSilvio TafuriSimone PerniolaFlorenzo IannoneGiuseppe LopalcoPublished in: RMD open (2022)
Continuing TNFi in patients with PsA throughout the vaccination did not hamper immunogenicity.